Novavax Inc., of Malvern, Pa., appointed Rick Bright vice president, vaccine research.
Nuvelo Inc., of La Jolla, Calif., said its chairman and CEO, Ted Love, was elected to the board of the California Healthcare Institute.
OncoGenex Technologies Inc., of Vancouver, British Columbia, appointed Stephen Anderson chief financial officer and Tom Bailey to its board.
OrthoLogic Corp., of Tempe, Ariz., appointed William Wardell to its board.
Oxford BioMedica plc, of Oxford, UK, promoted Mike McDonald to its board as an executive director.
Replidyne Inc., of Louisville, Colo., appointed Kirk Calhoun to its board and chairman of the audit committee.
Sirna Therapeutics Inc., of San Francisco, appointed Gregory Weaver senior vice president and chief financial officer.
Sirtris Pharmaceuticals, of Cambridge, Mass., appointed Garen Bohlin chief operating officer.
SkyePharma plc, of London, appointed Frank Condella CEO and Ken Cunningham chief operating officer.
Synthetic Genomics Inc., of Rockville, Md., appointed Aristides Patrinos president.
Trubion Pharmaceuticals Inc., of Seattle, appointed Steven Gillis to its board.
Xanthus Life Sciences Inc., of Cambridge, Mass., appointed Derek Winstanly to its board.